NEW YORK (GenomeWeb) – Investment bank UBS has initiated coverage of the genomics and molecular diagnostics space, saying technology advances will enable "the next wave of transformative innovations that will impact nearly every aspect of our lives," while "creating a unique opportunity for investors." 

Analyst Jon Groberg initiated coverage on a total of 16 firms, and gave six companies Buy ratings, nine companies Neutral ratings, and one firm a Sell rating. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.